Post I just made on IHUB:
Post# of 72445
(Total Views: 294)
Posted On: 03/05/2018 7:35:07 PM
Post I just made on IHUB: Longs, time for a reality check:
IPIX positives include Brilacidin already a multi-billion dollar drug with excellent results in Ulcerative Colitis, Oral Mucocitis, and Antibiotic Phase 2's completed. Strong indications that it will work equally effective in the dermatology field for Acne, Eczema, and Hidratenitis Suppurativa. Remember, Dr Bertolino was VP Dermatology at Pfizer and Director of Dermatology at Novartis so he should be pretty capable of recognizing what will/will not work and he stands strong behind B for dermatology. Kevetrin also a multi-billion dollar drug since it showed everything BP was looking for in the recent Ovarian Cancer trial, that of good p53 being activated and mutant p53 being destroyed. IPIX has 20 or so CDA's signed with major pharmaceutical firms showing extreme interest in our entire pipeline.
Now we don't have deals signed yet, but they appear to be very close and these will solve the financial concerns of IPIX forever. Many may claim these are just pipe dreams, but look at the science, look at the results, look at the CDA's, and draw your own conclusion. If you can't see that IPIX already is to become a multi-billion dollar player in the next number of months than bail immediately. If you have the cognitive ability to add 2+2 and arrive at 4 then you will make the decision to sit tight and wait for the Prurisol P2b trial results and the following news on possible deals or the path Leo intends to take the company before you do anything rash with your shares.
IPIX doesn't need good Prurisol results to survive and be a multi billion dollar player, they already have that assurance from my comments above. Prurisol has shown itself to be extremely safe, far safer by quantum levels compared to anything else on the market today, it is already in pill form, and it showed in a 200 dose arm from a previous trial to be equal to or better than Otezla even though it appeared to only be entering its effective zone at a 200 dose level. This trial is at 300 and 400 and again, just add 2+2, who doesn't believe we will see vastly superior efficacy in the P2b compared to the P2a. Sure, many may put up a wall of BS to try and make the trial look real risky, but that is where you have to call them on their lies and distortion. Prurisol being effective against Psoriasis isn't a life or death situation for iPIX, but it will prove IMO to be an extremely profitable revenue stream as I have come to the conclusion, based on prior clinical results, that it will become first in class as to preferred treatment for Psoriasis.
The real crutch of the IPIX story are the deals upcoming and exactly how BP values our pipeline. That is another perfect storm for IPIX as many BPs have dwindling current pipelines, they have lots and lots of repatriated cash to buy new pipelines, and IPIX appears to have the strongest pipeline that has come down the pike at one time in maybe the history of medicine. I expect Leo is having more of a problem in choosing the perfect partner as opposed to finding the perfect partner.
Add it all up, remember it is as easy as 2+2, and see if the current hysteria which those that have bet against the company are trying to whip up by playing many trading games thru questionable MM practices are totally understandable as they see their financial destruction looming on the very near horizon.
Are 3 more weeks worth waiting and not getting upset over whether the SP sinks a bit more due to the trading games being played?
Easy as 2 + 2 = 4 use your head, not your emotions
IPIX positives include Brilacidin already a multi-billion dollar drug with excellent results in Ulcerative Colitis, Oral Mucocitis, and Antibiotic Phase 2's completed. Strong indications that it will work equally effective in the dermatology field for Acne, Eczema, and Hidratenitis Suppurativa. Remember, Dr Bertolino was VP Dermatology at Pfizer and Director of Dermatology at Novartis so he should be pretty capable of recognizing what will/will not work and he stands strong behind B for dermatology. Kevetrin also a multi-billion dollar drug since it showed everything BP was looking for in the recent Ovarian Cancer trial, that of good p53 being activated and mutant p53 being destroyed. IPIX has 20 or so CDA's signed with major pharmaceutical firms showing extreme interest in our entire pipeline.
Now we don't have deals signed yet, but they appear to be very close and these will solve the financial concerns of IPIX forever. Many may claim these are just pipe dreams, but look at the science, look at the results, look at the CDA's, and draw your own conclusion. If you can't see that IPIX already is to become a multi-billion dollar player in the next number of months than bail immediately. If you have the cognitive ability to add 2+2 and arrive at 4 then you will make the decision to sit tight and wait for the Prurisol P2b trial results and the following news on possible deals or the path Leo intends to take the company before you do anything rash with your shares.
IPIX doesn't need good Prurisol results to survive and be a multi billion dollar player, they already have that assurance from my comments above. Prurisol has shown itself to be extremely safe, far safer by quantum levels compared to anything else on the market today, it is already in pill form, and it showed in a 200 dose arm from a previous trial to be equal to or better than Otezla even though it appeared to only be entering its effective zone at a 200 dose level. This trial is at 300 and 400 and again, just add 2+2, who doesn't believe we will see vastly superior efficacy in the P2b compared to the P2a. Sure, many may put up a wall of BS to try and make the trial look real risky, but that is where you have to call them on their lies and distortion. Prurisol being effective against Psoriasis isn't a life or death situation for iPIX, but it will prove IMO to be an extremely profitable revenue stream as I have come to the conclusion, based on prior clinical results, that it will become first in class as to preferred treatment for Psoriasis.
The real crutch of the IPIX story are the deals upcoming and exactly how BP values our pipeline. That is another perfect storm for IPIX as many BPs have dwindling current pipelines, they have lots and lots of repatriated cash to buy new pipelines, and IPIX appears to have the strongest pipeline that has come down the pike at one time in maybe the history of medicine. I expect Leo is having more of a problem in choosing the perfect partner as opposed to finding the perfect partner.
Add it all up, remember it is as easy as 2+2, and see if the current hysteria which those that have bet against the company are trying to whip up by playing many trading games thru questionable MM practices are totally understandable as they see their financial destruction looming on the very near horizon.
Are 3 more weeks worth waiting and not getting upset over whether the SP sinks a bit more due to the trading games being played?
Easy as 2 + 2 = 4 use your head, not your emotions
(7)
(0)